U.S. Markets closed

Independent Research on Trending Growth Companies: Northwest Biotherapeutics and Sanuwave Health

NEW YORK, NY / ACCESSWIRE / February 26, 2018 / Latest key findings by Growth Market Report for all traders, shareholders, and investors of Northwest Biotherapeutics, Inc. (NWBO) and Sanuwave Health Inc. (SNWV), including recent technical analysis and consolidated fundamental information.

Growth Market Report Initiates Coverage on:

NWBO DOWNLOAD: http://GrowthMarketReport.com/signup/?co=NWBO
SNWV DOWNLOAD: http://GrowthMarketReport.com/signup/?co=SNWV

Northwest Biotherapeutics, Inc. (NWBO) REPORT OVERVIEW

On February 23rd, 2018, Northwest Biotherapeutics, Inc. closed out the trading session at $0.29 (down 4.00%), compared to the previous day close of $0.30. The volume on the day was 2,011,187 (up 6.46%), compared to the company's previous day volume of 1,889,145. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Northwest Biotherapeutics reported revenue of $0.62MM vs $1.74MM (down 64.17%) and basic earnings per share -$0.77 vs -$1.48. Northwest Biotherapeutics is expected to report earnings on April 16th, 2018, the report will be for the fiscal period ending December 31, 2017.

Access Growth Market Report's Northwest Biotherapeutics, Inc. Research Report at:
http://GrowthMarketReport.com/signup/?co=NWBO

Sanuwave Health Inc. (SNWV) REPORT OVERVIEW

On February 23rd, 2018, Sanuwave Health, Inc. closed out the trading session at $0.33 (up 8.33%), compared to the previous day close of $0.30. The volume on the day was 640,671 (down 18.90%), compared to the company's previous day volume of 789,965. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Sanuwave Health reported revenue of $1.38MM vs $0.97MM (up 42.53%) and basic earnings per share -$0.06 vs -$0.08. Sanuwave Health is expected to report earnings on April 3rd, 2018, the report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.02. The estimated EPS forecast for the next fiscal year is -$0.02 and is expected to report on April 3rd, 2018.

Access Growth Market Report's Sanuwave Health, Inc. Research Report at:
http://GrowthMarketReport.com/signup/?co=SNWV

Our Actionable Research on Northwest Biotherapeutics, Inc. (NWBO) and Sanuwave Health Inc. (SNWV) can be downloaded free of charge at http://GrowthMarketReport.com.

ABOUT Growth Market Report

It's no secret that Wall Street analysts spend the lion's share of their time focused on large, well-known companies and securities - they make most of their money from investment banking. As a result, small cap companies are relatively underserved when it comes to top-quality research and analysis. Growth Market Report was developed to fill in that gap.

DISCLAIMER

Growth Market Report is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at http://GrowthMarketReport.com.

PRESS RELEASE PROCEDURES

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst, provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by Growth Market Report. Growth Market Report is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

Growth Market Report, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. Growth Market Report, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, Growth Market Report, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither Growth Market Report nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever.

MEDIA CONTACT:

Jack Sutherland, Media Department
Office: +1 (205) 217-4026
E-mail: media@GrowthMarketReport.com

SOURCE: Growth Market Report